First human tests begin for new weight and diabetes drug
NCT ID NCT06945419
Summary
This is an early-stage study to check the safety and how the body processes a new drug called LY4086940. It will involve healthy people and people who are overweight, have obesity, or have type 2 diabetes. The main goal is to see how well the drug is tolerated and to measure its levels in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Pharmacology of Miami
NOT_YET_RECRUITINGMiami, Florida, 33172, United States
Contact Phone: •••-•••-••••
Contact
-
Endeavor Clinical Trials
RECRUITINGSan Antonio, Texas, 78240, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit
RECRUITINGDaytona Beach, Florida, 32117, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit
RECRUITINGDallas, Texas, 75247, United States
Contact Phone: •••-•••-••••
Contact
-
Lilly Centre for Clinical Pharmacology
COMPLETEDSingapore, 138623, Singapore
Conditions
Explore the condition pages connected to this study.